Skip to main content
logo
AlzeCure Pharma AB (publ) (STO:ALZCUR)
Sweden flag Sweden · Delayed Price · Currency is SEK
8.08
+0.14 (1.76%)
Sep 2, 2026, 5:29 PM CET

AlzeCure Pharma AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
97.33-----
Revenue Growth
------
Gross Profit
97.33-----
Operating Income
30.25-47.97-35.99-38.34-56.57-78.14
Net Income
30.72-47.65-35.35-37.17-56.24-77.78
Earnings Per Share
0.27-0.47-0.46-0.60-1.18-2.06
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
13.4950.3431.529.125.5841.74
Total Debt
2.013.864.93---
Net Cash (Debt)
11.4846.4826.5729.125.5841.74
Net Cash Growth
-8.69%74.96%-8.71%13.77%-38.73%-62.88%
Net Cash Per Share
0.100.460.340.470.541.11

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-52.48-34.59-34.233.06-99.91-70.64
Capital Expenditures
---0.12---0.05
Free Cash Flow
-52.48-34.59-34.353.06-99.91-70.69
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%-----
Operating Margin
31.08%-----
Profit Margin
31.56%-----
FCF Margin
-53.92%-----

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-7.337.332.35--
P/FCF Ratio
---63.16--